Simulations Plus Inc
NASDAQ:SLP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Simulations Plus Inc (SLP) under the Base Case is USD per share.
Compared with the current market price of 18.5 USD, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Our estimate of what one share is worth.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Simulations Plus Does
Simulations Plus makes software that helps drug companies predict how a medicine will behave in the body before they spend heavily on lab and human testing. Its tools are used for tasks like modeling absorption, distribution, metabolism, and drug interactions, and the company also sells consulting services to help customers use those tools in real drug programs.
- Headquarters
- United States of America US
- Employees
- 212
- IPO date
- Jun 18, 1997
Revenue & Expenses Breakdown
Simulations Plus Inc
Earnings Waterfall
Simulations Plus Inc
What is the Intrinsic Value of one SLP stock?
The intrinsic value for Simulations Plus Inc (SLP) under the Base Case is USD.
Is SLP stock undervalued or overvalued?
Compared with the current market price of 18.5 USD, the stock appears .
